SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1

Hemasphere. 2019 Oct 1;3(6):e301. doi: 10.1097/HS9.0000000000000301. eCollection 2019 Dec.

Authors

Sandro Altamura^{1

2}, Ute Schaeper³, Sibylle Dames³, Kathrin Löffler³, Mona Eisermann³, Christian Frauendorf³, Katja Müdder^{1

2}, Joana Neves¹, Martina U Muckenthaler^{1

2}

Affiliations

¹ Department of Pediatric Hematology, Oncology and Immunology - University of Heidelberg, Germany.
² Molecular Medicine Partnership Unit, Heidelberg, Germany.
³ Silence Therapeutics GmbH, Berlin, Germany.

No abstract available

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.